NRSNW · NeuroSense Therapeutics Ltd. · Documents
Market Cap
$4.50M
Shares
1.90M
Volume · Oct 28
258
Avg daily vol (26 sessions)
4988
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2022-11-29 | — | |
| 6-K | — | 2022-11-16 | — | |
| 6-K | — | 2022-11-15 | — | |
| 6-K | — | 2022-11-03 | — | |
| 6-K | — | 2022-10-12 | — | |
| 6-K | — | 2022-09-28 | — | |
| 6-K | — | 2022-09-20 | — | |
| 6-K | — | 2022-09-16 | — | |
| 6-K | — | 2022-08-31 | — | |
| 6-K | — | 2022-08-16 | — | |
| 6-K | — | 2022-08-09 | — | |
| 6-K | — | 2022-08-02 | — | |
| 6-K | — | 2022-08-01 | — | |
| 6-K | — | 2022-07-28 | — | |
| 6-K | — | 2022-07-18 | — | |
| 6-K | — | 2022-07-13 | — | |
| 6-K | — | 2022-07-05 | — | |
| 6-K | — | 2022-07-01 | — | |
| 6-K | — | 2022-06-30 | — | |
| 6-K | — | 2022-06-29 | — | |
| 6-K | — | 2022-06-27 | — | |
| 6-K | — | 2022-06-22 | — | |
| 6-K | — | 2022-06-07 | — | |
| 6-K | — | 2022-06-01 | — | |
| 6-K | — | 2022-05-31 | — | |
| 6-K | — | 2022-05-19 | — | |
| 6-K | — | 2022-05-11 | — | |
| 6-K | — | 2022-05-02 | — | |
| 20-F | — | 2022-04-14 | 2021-12-31 | |
| 6-K | — | 2022-04-11 | — | |
| 6-K | — | 2022-03-30 | — | |
| 6-K | — | 2022-03-25 | — | |
| 6-K | — | 2022-03-21 | — | |
| 6-K | — | 2022-03-15 | — | |
| 6-K | — | 2022-02-15 | — | |
| 6-K | — | 2022-01-31 | — | |
| 6-K | — | 2022-01-27 | — | |
| 6-K | — | 2022-01-26 | — | |
| 6-K | — | 2022-01-04 | — | |
| 6-K | — | 2021-12-13 | — | |
| F-1/A | — | 2021-12-06 | — | |
| F-1/A | — | 2021-11-19 | — | |
| F-1/A | — | 2021-11-10 | — | |
| F-1/A | — | 2021-11-01 | — | |
| F-1 | — | 2021-10-18 | — |
Showing 151–195 of 195 filings